ON DEMAND: What does the COVID-19 pandemic mean for rheumatology now and in the future?


This week, a panel of leading rheumatologists joined us to discuss the risks of COVID-19 for people living with rheumatological diseases, key insights from the COVID-19 Global Rheumatology Alliance, and if and how to adapt therapy during the current pandemic.

With a live cross to the UK, we heard from Dr James Galloway, a  rheumatologist and clinical researcher, about his experience managing patients on the frontline, as well as insights into the clinical trials currently exploring potential treatments for COVID-19.

Watch the full recording here: 

Listen to the podcasts here: 

This webinar was developed independently by the limbic. Thank you to Pfizer Australia Pty Ltd for providing the financial support that made it possible.

Already a member?

Login to keep reading.

OR
Email me a login link
logo

© 2022 the limbic